Treatment of recalcitrant atopic dermatitis with omalizumab

被引：141

作者：

Lane, JE ^{[1
]}

Cheyney, JM

Lane, TN

Kent, DE

Cohen, DJ

机构：

[1] Mercer Univ, Sch Med, Dept Internal Med, Div Dermatol, Macon, GA 31217 USA

[2] Emory Univ, Sch Med, Dept Dermatol, Atlanta, GA 30322 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2006年 / 54卷 / 01期

关键词：

D O I：

10.1016/j.jaad.2005.09.030

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Atopic dermatitis is a common diagnosis that presents a therapeutic challenge. Although multiple therapeutic modalities exist, there is no single monotherapy that has proven exceptional in ameliorating the symptoms of this disease. Current topical and systemic therapeutic options offer benefit but carry varying degrees of adverse effects that often limit their application. We present 3 patients with severe, recalcitrant atopic dermatitis successfully treated with omalizumab.

引用

页码：68 / 72

页数：5

共 19 条

[1] Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis [J].

Corren, J ;

Diaz-Sanchez, D ;

Saxon, A ;

Deniz, Y ;

Reimann, J ;

Sinclair, D ;

Davancaze, T ;

Adelman, D .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (03) :243-248

[2] Biochemical and immunologic mechanisms in atopic dermatitis: New targets for emerging therapies [J].

Hanifin, JM ;

Chan, S .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (01) :72-77

[3] IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis [J].

Hide, M ;

Tanaka, T ;

Yamamura, Y ;

Koro, O ;

Yamamoto, S .

ACTA DERMATO-VENEREOLOGICA, 2002, 82 (05) :335-340

[4] Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment):: INNOVATE [J].

Humbert, M ;

Beasley, R ;

Ayres, J ;

Slavin, R ;

Hébert, J ;

Bousquet, J ;

Beeh, KM ;

Ramos, S ;

Canonica, GW ;

Hedgecock, S ;

Fox, H ;

Blogg, M ;

Surrey, K .

ALLERGY, 2005, 60 (03) :309-316

[5] The high affinity receptor for IgE is the predominant IgE-binding structure in lesional skin of atopic dermatitis patients [J].

Klubal, R ;

Osterhoff, B ;

Wang, BH ;

Kinet, JP ;

Maurer, D ;

Stingl, G .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (03) :336-342

[6] Failure of omalizumab for treatment of severe adult atopic dermatitis [J].

Krathen, RA ;

Hsu, S .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (02) :338-340

[7] A role for eosinophils in atopic dermatitis [J].

Leiferman, KM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 45 (01) :S21-S24

[8] Cellular and immunologic mechanisms in atopic dermatitis [J].

Leung, DYM ;

Soter, NA .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) :S1-S12

[9] THE PRESENCE OF IGE ON MACROPHAGES AND DENDRITIC CELLS INFILTRATING INTO THE SKIN LESION OF ATOPIC-DERMATITIS [J].

LEUNG, DYM ;

SCHNEEBERGER, EE ;

SIRAGANIAN, RP ;

GEHA, RS ;

BHAN, AK .

CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 42 (03) :328-337

[10]

MAURER D, 1995, J IMMUNOL, V154, P6285

← 1 2 →